1. Tyrosine Kinase Inhibitors and Proton Pump Inhibitors: An Evaluation of Treatment Options

   • Roelof W. F. van Leeuwen
   • Frank G. A. Jansman
   • Ron H. J. Mathijssen

   Current Opinion Open access 18 January 2017 Pages: 683 - 688

   

2. Clinical Pharmacokinetics and Pharmacodynamics of Cediranib

   • Weifeng Tang
   • Alex McCormick
   • Eric Masson

   Review Article 09 December 2016 Pages: 689 - 702

   

3. Pharmacokinetic Characteristics and Clinical Efficacy of an SGLT2 Inhibitor Plus DPP-4 Inhibitor Combination Therapy in Type 2 Diabetes

   • André J. Scheen

   Review Article 30 December 2016 Pages: 703 - 718

4. Clinical Pharmacokinetics and Pharmacodynamics of Albiglutide

   • Andreas Brønden
   • Filip K. Knop
   • Mikkel B. Christensen

   Review Article 03 January 2017 Pages: 719 - 731

   

5. A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients

   • Astrid W. Oosten
   • João A. Abrantes
   • Ron H. J. Mathijssen

   Original Research Article Open access 05 November 2016 Pages: 733 - 746

   

6. Drug Interactions Between Peficitinib, an Orally Administered, Once-Daily Janus Kinase Inhibitor, and Rosuvastatin in Healthy Subjects

   • Tong Zhu
   • Barbara Parker
   • James Keirns

   Original Research Article 22 November 2016 Pages: 747 - 757

   

7. Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients

   • Christian Radke
   • Dagmar Horn
   • Georg Hempel

   Original Research Article 31 December 2016 Pages: 759 - 779

   

8. Elucidating the Plasma and Liver Pharmacokinetics of Simeprevir in Special Populations Using Physiologically Based Pharmacokinetic Modelling

   • Jan Snoeys
   • Maria Beumont
   • Sivi Ouwerkerk-Mahadevan

   Original Research Article 29 November 2016 Pages: 781 - 792

   

9. Effect of Activated Charcoal on Rivaroxaban Complex Absorption

   • Edouard Ollier
   • Sophie Hodin
   • Xavier Delavenne

   Original Research Article 02 December 2016 Pages: 793 - 801

   

10. Comparison of a Novel Formulation of Abiraterone Acetate vs. the Originator Formulation in Healthy Male Subjects: Two Randomized, Open-Label, Crossover Studies

    • Ronald Goldwater
    • Azra Hussaini
    • Paul Nemeth

    Original Research Article Open access 19 April 2017 Pages: 803 - 813